Analyze will assess the Capability of its Red Grape Cell (RGC) Botanical Composition to Advertise Eye Wellness Study is very first to display likely abilities of BioHarvest’s Botanical-Synthesis technology to offer reliable APIs, adjuvants and medicines for pharmaceutical field Vancouver, British Columbia, and Rehovot, Israel–(Newsfile Corp. – February 14, 2023) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (“BioHarvest” or the “Company”) has announced a collaboration with the International Neurorehabilitation Institute (INI) (https://inirehab.com/) in Lutherville, Maryland to execute a clinical trial to assess the ability of its RGC composition to endorse eye well being. The examine will be led by Dr. Daniel Becker, Director of the INI and Assistant Professor…